德國欣髮源 Thymuskin

Nine physicians - professors at the universities who were oncologists, dermatologists, gynecologists and general internists - participated in the production of a thymus gland extract called ThymuSkin, a product they developed primarily for cancer patients who were subjected to chemotherapy.

九位醫師，包含腫瘤科醫生、皮膚科醫生、婦產科醫生和一般內科醫生參與有關胸腺胜肽（Thymuskin Peptides）系列產品研究，針對曾經接受化療患者的落髮治療結果。

The preceding progression shows a female with alopecia areata. Before treatment with ThymuSkin, after several weeks of treatment, after several months of treatment with ThymuSkin, then finally after a year and a half.

這是一位斑禿（圓禿Alopecia areata）的女性患者在使用德國欣髮源Thymuskin 治療過程的照片記錄，從零到治療數周後、治療數月後，最後在治療一年半後的結果。

These physicians performed placebo controlled, double-blind studies on the effects of this product on hair loss in cancer patients. When the product was rubbed on the patient's scalp before he/she took a chemotherapeutic agent, there was no hair fallout -- hair loss was kept at a minimum.. The German GMP subsequently declared the product to be a preventative for hair fallout for chemotherapy patients.

由這些醫生進行雙盲研究，對癌症患者掉髮的影響進行沒有使用與有使用德國欣髮源Thymuskin 產品的研究結果。

當她在接受化療藥物之前使用德國欣髮源Thymuskin 產品，落髮後遺症保持最低落髮量。

德國 GMP 隨即在這項研究後宣布德國欣髮源Thymuskin 產品是一種預防化療患者脫髮後遺症的產品。

However, it was soon discovered by the research physicians that ThymuSkin was very effective against rare types of hair loss and scalp disorders. So it was declared a treatment for the regrowth of hair. It has been proven to be effective for men 67% of the time, and for women 95% of the time who still have live hair follicles.

然而，研究醫生很快地發現德國欣髮源Thymuskin 是非常有效的對抗罕見類型的脫髮和頭皮疾病。因此德國欣髮源Thymuskin 系列產品，被宣布可以有效的為頭髮再生治療。

德國欣髮源Thymuskin 已經被證實是有效的治療男性67%與女性95%活化毛囊結果。

Complete remission in a 40 year old patient with alopecia areata totalis after 18 months local treatment with ThymuSkin.

這是一位40歲的圓禿患者，在經過德國欣髮源Thymuskin 治療18個月後完全恢復頭髮生長的結果。

The pictures above are typical in nature and taken from the Double Blind Placebo Controlled Studies involving over 3000 participants, conducted in eight leading hospitals and university clinics throughout Europe:
Vienna City Hospital - Austria Dept.of Surgery, Municipal Clinics of Darmstadt - University of Frankfurt, Ruprecht - Karls University of Heidelberg - Gynecological Clinic, University Clinic of Meunster - Oncology / Surgery, Medical Clinic of the University of Munich - Dept of Hematology/Oncology, Division of Pharmacology and Toxicology - University of Osnabrueck, The Medical University of Hanover and the German Cancer Research Center, Heidelberg.

上面的圖片是典型性質，超過3000名受試者在歐洲進行的雙盲安慰劑對照研究採取八個領先的醫院診所和大學包含：

維也納市立醫院-法蘭克福大學-奧地利Dept.of外科，達姆施塔特市的診所，魯普雷希特-海德堡卡爾斯大學-婦科診所，Meunster的大學醫院-腫瘤/外科手術，慕尼黑大學診所-血液學/腫瘤學，藥理學和毒理學科學系-奧斯納布呂克，漢諾威醫科大學大學德國癌症研究中心，海德堡。

Partial remission of a 37 year old patient with alopecia areata universalis for 14 years before treatment, after 9 months local treatment with THYMUSKIN

這是一位37歲患有普遍性圓禿14年的患者，在經過德國欣髮源Thymuskin 局部治療9個月後恢復頭髮生長的結果。

Therapeutic Successes Against Both Types of Alopecia

針對兩種落髮類型治療成功案例

Dr. med. Moessler’s results from her participating with Prof. Dr. med. Hagedorn in their third hair preservation and regrowth investigation were remarkable for changing the appearance of balding people. In her paper, she states:

Fifty-one patients with Alopecia androgenetica and sixteen patients with Alopecia areata were treated with Thymu-Skin (shampoo and tonic containing a thymus extract) over a period of twelve months. Sixty-seven percent of the male patients with androgenetic alopecia had a benefit from this treatment. In 83 percent of the patients with Alopecia areata, Thymu-Skin therapy resulted in partial or full regrowth of scalp hair. In female patients with Alopecia androgenetica the average daily hair loss (of individual hair strands) decreased from 139 (pretreatment) to 57 after twelve months. There was no remarkable change in male patients. In patients with Alopecia Areata the average hair loss (individual hair strands) decreased from initially 245 to 10.

Dr. Moessler醫學博士和Dr. Hagedorn醫學博士教授在他們的第三個頭髮保存和再生研究結果獲得顯著改變落髮患者的外觀。

在她的論文中說明：

進行十二個月的案例中有51例Alopecia androgenetica（雄性禿）和16例Alopecia areata（圓禿）患者採用德國欣髮源Thymuskin（洗髮精和含有胸腺提取物養髮液）。

‧男性患者雄性禿的67％受益於這項治療。

‧83%的圓禿患者在使用德國欣髮源Thymuskin 治療使頭皮頭髮部分或全部再生。

‧女性患者Alopecia androgenetica（雄性禿）在使用德國欣髮源Thymuskin 治療後12個月的平均每日落髮從139（治療前）降低至57（57根頭髮）。

有男性患者無明顯變化。

‧圓禿患者平均每日脫髮從治療前245下降到10（10根頭髮）。

The two specific Thymu-Skin products, hair shampoo and hair tonic manufactured by Thymu-Skin Cosmetic Klett-Loch GmbH of Manheim, Germany, were utilized to acquire such marvelous results in Dr. Moessler’s study.

The gel, hair mask, and conditioner crème rinse were not used because they did not exist then. The therapeutic successes against both types of alopecia were analyzed in relation to the duration of hair loss for individual patients—both men and women. A scoring system was developed using the following classification: “Improvement” was +1, “no change” was 0 and “progression” (of hair loss) was –1. The duration of hair loss was classified in intervals of 1 to 12 months, 13 to 30 months, 31 to 60 months, and more than 60 months.

在Dr. Moessler醫學博士的研究中證實：由德國Manheim的Cosmetic Klett-Loch GmbH 公司研發製造德國欣髮源Thymuskin 系列洗髮精和養髮液，使用這兩個特別的產品，獲得這了不起的結果。

不使用凝膠，髮膜，護髮素和乳霜。針對這兩種類型（雄性禿與圓禿）的落髮治療成功案例，男女雙方持續使用時間進行分析。

判斷是使用以下的方式記錄：“改進”為+1，“沒有變化”是0和“進步”（落髮持續）為-1。

落髮的持續時間被分類在區間1到12個月，13〜30個月，31〜60個月，超過60個月。

Telling the story of success or failure for hair preservation are the detailed results of Thymu-Skin usage shown below. They are divided into subjective improvement in relation to the duration of hair loss and objective therapeutic success evaluated by hair strand counts.

使用德國欣髮源Thymuskin 獲得以下結果表示保留頭髮成功與失敗。

在這裡分別表示使用德國欣髮源Thymuskin 產品治療的結果（主觀）與頭髮保留髮絲計數結果（客觀）。

Subjective Improvement Relating to Duration of Hair Loss Among Men from Androgenetic Alopecia (Male Pattern Baldness)

（主觀）受試者治療後的結果統計–有關於男性雄激素落髮（男性雄性禿）

For men with male pattern baldness (MPB) present for from 1 to 12 months, 20 percent observed improvement (+1), 20 percent had no change (0), and 60 percent observed hair loss progress (-1);

For men with MPB present for from 13-30 months, 50 percent (improvement (+1), 25 percent experienced no change (0), and 25 percent observed hair loss progression (-1);

For men with MPB present for from 31 to 60 months, 25 percent had improvement (+1), 75 percent saw no change (0), none progressed to further hair loss(-1).

‧對於男性雄性禿1-12個月：

20%的人獲得改善（+1）；20%的人沒有變化（0）；60%的人持續掉髮（-1）

‧對於男性雄性禿13-30個月：

50%的人獲得改善（+1）；25%的人沒有變化（0）；25%的人持續掉髮（-1）

‧對於男性雄性禿31-60個月：

25%的人獲得改善（+1）；75%的人沒有變化（0）；沒有人進一步掉髮（-1）

Objective Hair Strand Counts for Hair Preservation in Male Pattern Baldness

（客觀）在男性雄性禿頭髮保留髮絲計數結果

For men with MPB, the average number of daily hair strands lost by the male participants in this study was 119 before treatment, 98 after three months of treatment and only 76 after six months (less than the usual fallout of 80 strands per day).

在男性雄性禿，男性受試者在接受治療前每日平均落髮量達119根頭髮；在使用德國欣髮源Thymuskin 系列產品治療3個月後每日平均落髮量降低至98根頭髮；使用6個月後每日平均落髮量降低至76根頭髮（平均每天都低於80根頭髮）。

ThymuSkin Results for Female Pattern Baldness Are Superior

德國欣髮源Thymuskin 的治療在女性雄性禿的結果非常卓越

對於女性雄性禿（Female Pattern Baldness）使用德國欣髮源Thymuskin胸腺胜肽治療比局部使用小牛胸腺提取物含有的營養物質的影響更好。

譯者在這裡特別補充：

德國欣髮源 Thymuskin Peptides –活性複合物GKL02胸腺胜肽，從蔬菜水果以高生物科技發酵技術合成，其純度與活性比起從小牛、小羊提取的胸腺素高於 150 倍，更可以降低狂牛症、素食主義者等顧忌。

Women’s Subjective Impressions About Thymu-Skin Usage for FPB

女性對於有關於女性雄激素落髮的主觀印象（女性雄性禿）

For women with FPB, 49 percent had the impression that new hair growth was present after three months. They observed improvement (+);

For women with FPB, 51 percent saw no change (0) in three months of product usage;

For women with FPB, 72 percent experienced good new hair growth-improvement (+1)—after six months of usage;

For women with FPB, 21 percent saw no change (0) in six months;

For women with FPB, 7 percent observed a progression of hair loss after six months of product use;

For women with FPB, 19 percent observed no change (0) after nine months;

For women with FPB, 14 percent felt that hair loss progression (-1) had occurred.

‧對於女性雄性禿 49% 使用者的印象是觀察到獲得改善，使用三個月後感覺頭髮新生（+）

‧對於女性雄性禿 51% 認為使用三個月後沒有明顯改變（0）

‧對於女性雄性禿 72% 使用者經歷良好的改善，感覺到健康頭髮新生。在使用六個月後（+1）

對於女性雄性禿 21% 認為在六個月內沒有改變（0）

對於女性雄性禿 7% 使用六個月後，觀察到掉髮的趨勢

對於女性雄性禿 19% 使用九個月後，沒有觀察到變化（0）

對於女性雄性禿 14% 認為掉髮增加的情況發生（-1）

At the conclusion of this study, all of the participating women stated their personal satisfaction with therapeutic success they experienced in treating androgenetic alopecia. Their hair loss either stopped or they saw new hair growth with which they were highly pleased.

在這項研究結束時，所有參與的女性對於治療女性雄性禿結果表示他們個人治療成功的滿意度。他們非常滿意，因為他們的脫髮停止，或者他們看到了新生長的頭髮。

Subjective Improvement Relating to Duration of Hair Loss Among Women from Androgenetic Alopecia (Female Pattern Baldness)

（主觀）受試者治療後的結果統計–有關於女性雄激素落髮（女性雄性禿）

For women with female pattern baldness (FPB) present for from 1 to 12 months, 83 percent observed improvement (+1), 17 percent had no change (0), and none of the women observed further hair loss progression (-1);

For women with (FPB) present for from 13 to 30 months, 78 percent had improvement (+1), 22 percent experienced no change (0), and none observed any progression (-1) to further hair loss;

For women with FPB present for from 31-60 months, 60 percent had improvement (+1), 22 percent saw no change (0), and, surprisingly, 18 percent reported they had progressed to further hair loss (-1).

‧對於女性雄性禿1-12個月：

83%的人獲得改善（+1）；17%的人沒有變化（0）；0% 沒有人持續掉髮（-1）

‧對於女性雄性禿 13-30個月：

78%的人獲得改善（+1）；22%的人沒有變化（0）；0% 沒有人持續掉髮（-1）

‧對於女性雄性禿 31-60個月：

60%的人獲得改善（+1）；22%的人沒有變化（0）；令人訝異的是：報告指出18%的人進一步掉髮（-1）

Objective Hair Strand Counts for Hair Preservation in Female Pattern Baldness

（客觀）在女性雄性禿頭髮保留髮絲計數結果

For women with FPB, the average number of daily hair strands lost by the female participants in this study was 139 before treatment with the calf thymus extract, 90 after three months of treatment, 80 after six months, and 57 after twelve months (less than the usual female hair fallout).

對於女性雄性禿，女性受試者在這項研究使用小牛胸腺提取物治療前平均每日落髮量為139根頭髮；在使用德國欣髮源Thymuskin 產品治療3個月後，平均每日落髮量達90根頭髮；使用6個月後平均每日落髮量降低至80根頭髮；使用12個月後平均每日落髮量降低至57根頭髮（低於一般女性落髮量）。

Subjective Improvement Relating to Duration of Hair Loss from Alopecia Areata (AA) Among Both Sexes

（主觀）受試者治療後的結果統計–在男性與女性之間發生的圓禿（AA）

For study participants having AA present for from 1 to 12 months, 40 percent observed improvement (+1), 40 percent had no change (0), and 20 percent observed hair loss progression (-1);

For subjects with AA present for from 13 to 30 months, 50 percent had improvement (+1), 40 percent saw no change (0), and none progressed to further loss (-1).

對於研究受試者發生圓禿（AA）到目前為止1至12個月者，40％的受試者獲得改善（1）；40％的人沒有變化（0）；20％持續掉髮（-1）

對於研究受試者發生圓禿（AA）到目前為止13〜30個月，50％有改善（1），40％的人認為沒有變化（0），並沒有人進一步掉髮（-1）。

For all patients with a duration of hair loss of more than 60 months, new hair growth was observed where there had been bare scalp patches before.

對於維持圓禿超過60個月的圓禿患者，觀察到在圓禿的區塊有新髮生長。

Objective Hair Strand Counts for Hair Preservation in Alopecia Areata

（客觀）在圓禿頭髮保留髮絲計數結果

For men and women having AA, the average number of daily hair strands lost by the participation in this study was 245 before treatment with the shampoo and tonic of Thymu-Skin, 195 after three months of treatment, 164 after six months, 80 after nine months, and only 10 after twelve months.

During the total period of treatment, Thymu-Skin showed no local or systemic adverse side effects, except that T-lymphocyte counts improved somewhat, which was a positive immune system response.

對於有圓禿的男性與女性患者，在這項研究使用德國欣髮源Thymuskin 治療前平均每日落髮量為245根頭髮；在使用德國欣髮源Thymuskin 高效生物活性洗髮精與養髮精華液治療3個月後，平均每日落髮量降低至195根頭髮；使用6個月後平均每日落髮量降低至164根頭髮；使用9個月內平均每日落髮量降低至80根頭髮；使用12個月內降低至10根頭髮。

在整個治療過程中，德國欣髮源Thymuskin 沒有表現出局部或全身的副作用，除了T淋巴細胞計數有所提高，但這是一個積極的免疫系統反應。

Subjective Impressions About Thymu-Skin Usage for Alopecia Areata (AA)

受試者對於德國欣髮源Thymuskin 使用於圓禿的反應（AA）

For men and women participants in this study who had AA, 31 percent had the impression that new hair growth was present after three months. They observed improvement (+1);

44 percent saw no change (0) in three months of product usage;

25 percent observed progression toward more hair loss;

47 percent experienced good new hair growth—an improvement (+1)—after six months of usage;

33 percent saw no change (0) in six months;

20 percent observed a progression of hair loss after six months of product use;

75 percent observed much improvement (+1) after nine months of self-administering Thymu-Skin

17 percent observed no change (0) after nine months;

8 percent felt that hair loss progression (-1) had occurred;

對於男性和女性圓禿患者參與這項研究，31％的人的印象是獲得改善，三個月後新的頭髮生長（1）

44％的人認為在使用產品三個月後沒有變化（0）

25％的人觀察到進一步持續掉髮

47％的人經歷過健康的頭髮新生，在使用六個月後獲得改善（1）

33％的人認為在六個月內沒有變化（0）

20％的人觀察到進一步持續掉髮，在使用產品半年後

75％的人觀察到大幅改善，在自我主導使用德國欣髮源Thymuskin 九個月後（+1）

17％的人認為在九個月內沒有變化（0）

8％的人觀察到進一步持續掉髮（-1）已經發生

After twelve months of local therapy with Thymu-Skin there was no progression toward further hair loss, but rather improvement in 86 percent of patients with alopecia areata. In 14 percent the status of their hair growth did not change.

在使用德國欣髮源Thymuskin 局部治療12個月後沒有再進一步的脫髮，對於圓禿患者有86%獲得改善。14%的受試者頭髮生長狀態並沒有改變。

原文網址：http://www.onlyhairloss.com/thymuskin/research.htm